/
Analyses & Displays for Hepatotoxicity

Analyses & Displays for Hepatotoxicity

Owned by Former user (Deleted)
Last updated: Dec 18, 2024 by Nicola Newton

Project Scope 

This project team will create a users guide or White Paper with recommendations for analyses and displays associated with Hepatotoxicity, with a focus on Phase 2-4 clinical trials and integrated submission documents.

Project LeadsEmail

Melvin Munsaka, AbbVie

melvin.munsaka@abbvie.com

Terry Walsh, Astellas

terry.walsh@astellas.com

Nicola Newton, PHUSE Project Assistant

nicky@phuse.global

CURRENT STATUS Q4 2024

  • Finalise Stage 1 white paper following public review.
  • Get Stage 2 white paper ready for public review.

Objectives & Deliverables

Timelines 

Finalise Stage 1 of draft White Paper

Q4 2023

Related content